Testicular Cancer Risk Stratification

Clinical Context

The National Comprehensive Cancer Network guidelines note that tumor size ≥4 cm is used as a prognostic indicator for occult metastases in seminoma patients, but this cutoff applies to tumor size, not normal testicular dimensions 1, 2, 3, 4
The 2012 NCCN guidelines specifically state that risk-adapted management using tumor size >4 cm was discouraged after validation studies showed it was not a reliable predictor of relapse 5, 6

A testicular volume <12 mL is considered atrophic, particularly in men <40 years, according to the American Urological Association 7
Pain, firmness, or mass effect in the testis warrants evaluation, as noted by the European Association of Urology 1

The 4 cm threshold in guidelines refers to tumor dimensions within the testis, not the overall testicular size itself, as clarified by the National Comprehensive Cancer Network 1, 2, 3, 4, 6, 8

The European Society for Medical Oncology guidelines indicate that a tumor size threshold of ≥4 cm with rete testis invasion is associated with a 32% relapse risk in seminoma patients, applying only to pathologic tumor measurements 9, 10
The National Comprehensive Cancer Network is not directly cited for this fact, however, the Annals of Oncology guidelines specify that the 4 cm cutoff refers to tumor dimensions within the testis, not the overall testicular size itself 9, 10, 11

Testicular atrophy, defined as volume <12 mL, warrants further evaluation, particularly in men under 40 years of age, with a 34% risk of germ cell neoplasia in situ in atrophic testes 12, 10
Volume <16 mL prompts consideration for contralateral testis biopsy in testicular cancer patients, according to the Annals of Oncology guidelines 9, 10, 11

Testicular volumes <12 mL are considered small or atrophic and warrant further investigation, particularly in men under 40 years of age, according to the European Urology guidelines 13

Testicular atrophy (volume <12 mL) warrants evaluation for underlying causes including cryptorchidism history, prior trauma, infections, chronic diseases, or genetic conditions, as recommended by The Journal of Urology 14
The 4cm threshold mentioned in cancer guidelines refers to tumor size within the testis, NOT overall testicular dimensions, as stated in the Annals of Oncology guidelines 15

Annual assessment of testicular position and size is recommended, particularly if you have a history of retractile testes or testicular ascent, according to The Journal of Urology guidelines 14
Self-examination monthly to detect any changes in size, firmness, or development of masses is advised by the European Urology guidelines 13